Literature DB >> 19184352

Concentrations of alpha- and beta-defensins in plasma of patients with inflammatory bowel disease.

N Yamaguchi1, H Isomoto, H Mukae, H Ishimoto, K Ohnita, S Shikuwa, Y Mizuta, M Nakazato, S Kohno.   

Abstract

BACKGROUND: Impaired production/release of defensins, representative endogenous antimicrobial peptides, is associated with the pathogenesis of inflammatory bowel disease (IBD).
MATERIAL AND METHODS: Employing in house radioimmunoassay, we examined concentrations of the major forms alpha-defensins, human neutrophil peptides (HNP) 1-3 and human beta-defensin (HBD)-2 in plasma of 55 IBD patients consisting of 29 patients with ulcerative colitis (UC) and 26 with Crohn's disease (CD) and 57 controls.
RESULTS: The circulating HNP 1-3, but not HBD-2, levels in IBD patients were significantly higher than those in controls. Plasma HNP 1-3 concentrations in CD patients significantly correlated with Crohn's disease activity index, peripheral white blood cell counts, serum CRP values and TNF-alpha levels.
CONCLUSIONS: Elevation of circulating alpha-defensins levels is suggestive of their physiopathological roles in IBD. Plasma HNP 1-3 concentrations may be an indicator for CD activity and their association with CRP and TNF-alpha supports a possible association with the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184352     DOI: 10.1007/s00011-008-8120-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  9 in total

1.  Alpha-defensin DEFA1A3 gene copy number elevation in Danish Crohn's disease patients.

Authors:  Cathrine Jespersgaard; Peder Fode; Marianne Dybdahl; Ida Vind; Ole Haagen Nielsen; Claudio Csillag; Pia Munkholm; Ben Vainer; Lene Riis; Margarita Elkjaer; Natalia Pedersen; Elisabeth Knudsen; Paal Skytt Andersen
Journal:  Dig Dis Sci       Date:  2011-06-24       Impact factor: 3.199

Review 2.  Pathobiology of neutrophil-epithelial interactions.

Authors:  Jennifer C Brazil; Charles A Parkos
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

Review 3.  The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.

Authors:  Jennifer C Brazil; Nancy A Louis; Charles A Parkos
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

4.  Alpha-defensins (α-Defs) in Crohn's disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utility.

Authors:  E Cerrillo; I Moret; M Iborra; D Ramos; E Busó; L Tortosa; E Sáez-González; P Nos; B Beltrán
Journal:  Clin Exp Immunol       Date:  2018-01-10       Impact factor: 4.330

Review 5.  Antimicrobial peptides and colitis.

Authors:  Samantha Ho; Charalabos Pothoulakis; Hon Wai Koon
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 6.  Antimicrobial proteins in intestine and inflammatory bowel diseases.

Authors:  Jung Mogg Kim
Journal:  Intest Res       Date:  2014-01-28

7.  Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients.

Authors:  Ehab H Mattar; Hussein A Almehdar; Abdullah A AlJaddawi; Isam ElDin M Abu Zeid; Elrashdy M Redwan
Journal:  J Immunol Res       Date:  2016-06-20       Impact factor: 4.818

8.  Antimicrobial peptides and the gut microbiome in inflammatory bowel disease.

Authors:  John Gubatan; Derek R Holman; Christopher J Puntasecca; Danielle Polevoi; Samuel Js Rubin; Stephan Rogalla
Journal:  World J Gastroenterol       Date:  2021-11-21       Impact factor: 5.742

9.  A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease.

Authors:  R Gacesa; A Vich Vila; V Collij; Z Mujagic; A Kurilshikov; M D Voskuil; E A M Festen; C Wijmenga; D M A E Jonkers; G Dijkstra; J Fu; A Zhernakova; F Imhann; R K Weersma
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.